The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

Mareike S Pötsch; Anika Tschirner; Sandra Palus; Stephan von Haehling; Wolfram Doehner; John Beadle; Andrew Coats; Stefan D Anker; Jochen Springer

doi:10.1007/s13539-013-0125-7

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

Mareike S Pötsch, Anika Tschirner, Sandra Palus, Stephan von Haehling, Wolfram Doehner, John Beadle, Andrew Coats, Stefan D Anker, Jochen Springer

Research output: Contribution to journal › Article › peer-review

53 Citations (Scopus)

Abstract

Sarcopenia, the age-related, progressive loss of skeletal muscle mass, strength, and function, is a considerable socioeconomic burden by increasing risks of falls, fractures, and frailty. Moreover, sarcopenic patients are often obese and therapeutic options are very limited.

Original language	English
Pages (from-to)	149-158
Number of pages	10
Journal	Journal of Cachexia, Sarcopenia and Muscle
Volume	5
Issue number	2
Early online date	22 Nov 2013
DOIs	https://doi.org/10.1007/s13539-013-0125-7
Publication status	Published - Jun 2014

Access to Document

10.1007/s13539-013-0125-7

Cite this

@article{d5cceff739f844b7997c60304cb9015c,

title = "The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats",

abstract = "Sarcopenia, the age-related, progressive loss of skeletal muscle mass, strength, and function, is a considerable socioeconomic burden by increasing risks of falls, fractures, and frailty. Moreover, sarcopenic patients are often obese and therapeutic options are very limited.",

author = "P{\"o}tsch, {Mareike S} and Anika Tschirner and Sandra Palus and {von Haehling}, Stephan and Wolfram Doehner and John Beadle and Andrew Coats and Anker, {Stefan D} and Jochen Springer",

year = "2014",

month = jun,

doi = "10.1007/s13539-013-0125-7",

language = "English",

volume = "5",

pages = "149--158",

journal = "Journal of Cachexia, Sarcopenia and Muscle",

issn = "2190-5991",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

AU - Pötsch, Mareike S

AU - Tschirner, Anika

AU - Palus, Sandra

AU - von Haehling, Stephan

AU - Doehner, Wolfram

AU - Beadle, John

AU - Coats, Andrew

AU - Anker, Stefan D

AU - Springer, Jochen

PY - 2014/6

Y1 - 2014/6

N2 - Sarcopenia, the age-related, progressive loss of skeletal muscle mass, strength, and function, is a considerable socioeconomic burden by increasing risks of falls, fractures, and frailty. Moreover, sarcopenic patients are often obese and therapeutic options are very limited.

AB - Sarcopenia, the age-related, progressive loss of skeletal muscle mass, strength, and function, is a considerable socioeconomic burden by increasing risks of falls, fractures, and frailty. Moreover, sarcopenic patients are often obese and therapeutic options are very limited.

U2 - 10.1007/s13539-013-0125-7

DO - 10.1007/s13539-013-0125-7

M3 - Article

C2 - 24272787

SN - 2190-5991

VL - 5

SP - 149

EP - 158

JO - Journal of Cachexia, Sarcopenia and Muscle

JF - Journal of Cachexia, Sarcopenia and Muscle

IS - 2

ER -